What are cervical cancer?

Bevacizumab is one of the most commonly used targeted drugs for cervical cancer. It mainly binds to vascular endothelial growth factor and prevents its interaction with the receptor, thereby inhibiting the formation of new blood vessels and achieving anti-tumor effect. Bevacizumab is often used in combination with chemotherapy for the treatment of advanced recurrent or metastatic cervical cancer.

2

. Epidermal growth factor receptor antagonists such

as cetuximab and trastuzumab can inhibit the proliferation and migration of tumor cells by blocking the signal transduction of epidermal growth factor receptor.